Breast MRI

Magnetic resonance imaging of the breast (breast MRI), commonly used for dense breasts, is a highly accurate imaging modality for detecting early breast cancer and other abnormalities without using excess radiation. It’s often used alongside digital mammograms and digital breast tomosynthesis to offer detailed visualization of breast lesion margins. 

Thumbnail

Fast breast MRI ready for clinical use following shorter read times, accurate cancer detection

Abbreviated MRI protocols not only shorten exam times but may significantly reduce costs and improve breast cancer screening overall.

mammography mammogram breast cancer

Here’s how radiologists should manage COVID-19 vaccine side effects spotted on breast MRI exams

Doctors have increasingly been seeing breast exams with swollen lymph nodes imitating cancer in patients who have received a vaccine, prompting Penn Medicine providers to offer up guidance.

Thumbnail

New suspicious findings on breast MRI performed during therapy are unlikely to be cancer

University of California, San Francisco, researchers found unusual lesions in 5.5% of cases and none were malignant.

Thumbnail

Breast MRI in cancer survivors results in more unneeded biopsies

Adding MRI to mammography screening for breast cancer detects more cancers, but results in more unnecessary biopsies, according to a June 4 study published in Radiology.

Thumbnail

Short-interval follow-up MRI helps ID early stage breast cancer

The researchers analyzed the frequency and cancer yield of ACR Breast Imaging Reporting and Data System (BI-RADS) 3 lesions in patients who received baseline and non-baseline screening MRIs.

Thumbnail

Researchers detail MRI’s role in identifying early-stage breast cancer

Short-interval follow-up MRI is an effective tool for identifying early-stage breast cancer, according to findings to be presented at the American Roentgen Ray Society (ARRS) 2019 Annual Meeting in Honolulu.

Thumbnail

Breast MRI may help personalize treatment for DCIS patients

Pairing breast MRI with a test that characterizes breast cancer genes can lead to a more personalized treatment approach for patients with ductal carcinoma in situ (DCIS), reported authors of a recent study published in JAMA Oncology.

Thumbnail

Insurer's price calculator severely underestimates breast MRI cost for Philadelphia woman

Although many insurance providers have invested in price calculators for patients to determine out-of-pocket costs, one Philadelphia woman discovered they may severely underestimate actual prices for services, according to a recent report by The Philadelphia Inquirer.